InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), announces today that Mr. Ehud Barak ...

Appointment Deepens Financial and Operational Expertise of Boardas Company Approaches Potential CommercializationSOUTH SAN FRANCISCO, Calif., ...

Dr. Gehchan brings 20 years of U.S. and international experience across multiple therapeutic areas, including immunology, as both an accomplished pharmaceutical executive and a physician to this newly ...

No. 3 / 2025Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

In trading on Thursday, shares of NewAmsterdam Pharma Company N V (Symbol: NAMS) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low as $19.60 per share.

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Getting addicted, no pun intended, to an animated conspiracy thriller from Adult Swim ...

Failed honey biotech firm TRG Natural Pharmaceuticals owes creditors more than $1.2 million, according to the liquidators’ first report. The Tauranga-based company was placed into liquidation at the ...

Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) has been assigned an average rating of “Buy” from the nine ratings firms that are presently covering the company, Marketbeat Ratings reports.

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in ...